$BLUE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in bluebird bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in bluebird bio, Inc.. Get notifications about new insider transactions in bluebird bio, Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 13 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2020 | BLUE | bluebird bio, Inc. | Vachon Mark | Grant | A | 0.00 | 157 | 0 | 2,157 | 2 K to 2.2 K (+7.85 %) | |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | Sellers William R. | Option Exercise | A | 64.09 | 3,000 | 192,270 | 3,000 | ||
| Jun 22 2020 | BLUE | bluebird bio, Inc. | Sellers William R. | Grant | A | 0.00 | 1,500 | 0 | 3,612 | 2.1 K to 3.6 K (+71.02 %) | |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | Sellers William R. | Grant | A | 0.00 | 112 | 0 | 2,112 | 2 K to 2.1 K (+5.60 %) | |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | Schenkein David P | Option Exercise | A | 64.09 | 3,000 | 192,270 | 3,000 | ||
| Jun 22 2020 | BLUE | bluebird bio, Inc. | Schenkein David P | Grant | A | 0.00 | 1,500 | 0 | 6,832 | 5.3 K to 6.8 K (+28.13 %) | |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | Schenkein David P | Grant | A | 0.00 | 156 | 0 | 5,332 | 5.2 K to 5.3 K (+3.01 %) | |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | MELTON DOUGLAS | Option Exercise | A | 64.09 | 3,000 | 192,270 | 3,000 | ||
| Jun 22 2020 | BLUE | bluebird bio, Inc. | MELTON DOUGLAS | Grant | A | 0.00 | 1,500 | 0 | 6,324 | 4.8 K to 6.3 K (+31.09 %) | |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | MELTON DOUGLAS | Grant | A | 0.00 | 124 | 0 | 4,824 | 4.7 K to 4.8 K (+2.64 %) | |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | DIXON WENDY L | Option Exercise | A | 64.09 | 3,000 | 192,270 | 3,000 | ||
| Jun 22 2020 | BLUE | bluebird bio, Inc. | DIXON WENDY L | Grant | A | 0.00 | 1,500 | 0 | 5,653 | 4.2 K to 5.7 K (+36.12 %) | |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | DIXON WENDY L | Grant | A | 0.00 | 153 | 0 | 4,153 | 4 K to 4.2 K (+3.83 %) | |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | Agwunobi John O | Option Exercise | A | 64.09 | 3,000 | 192,270 | 3,000 | ||
| Jun 22 2020 | BLUE | bluebird bio, Inc. | Agwunobi John O | Grant | A | 0.00 | 1,500 | 0 | 6,324 | 4.8 K to 6.3 K (+31.09 %) | |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | Agwunobi John O | Grant | A | 0.00 | 124 | 0 | 4,824 | 4.7 K to 4.8 K (+2.64 %) | |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Option Exercise | A | 64.09 | 4,200 | 269,178 | 4,200 | ||
| Jun 22 2020 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Grant | A | 0.00 | 2,100 | 0 | 7,959 | 5.9 K to 8 K (+35.84 %) | |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Grant | A | 0.00 | 259 | 0 | 5,859 | 5.6 K to 5.9 K (+4.63 %) | |
| Jun 08 2020 | BLUE | bluebird bio, Inc. | WENTWORTH KORY JAMES | Principal Accountin ... | Sell | S | 65.56 | 62 | 4,065 | 10,190 | 10.3 K to 10.2 K (-0.60 %) |
| Jun 08 2020 | BLUE | bluebird bio, Inc. | WENTWORTH KORY JAMES | Principal Accountin ... | Sell | S | 65.01 | 92 | 5,981 | 10,252 | 10.3 K to 10.3 K (-0.89 %) |
| Jun 08 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Sell | S | 65.56 | 69 | 4,524 | 22,387 | 22.5 K to 22.4 K (-0.31 %) |
| Jun 08 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Sell | S | 65.01 | 101 | 6,566 | 22,456 | 22.6 K to 22.5 K (-0.45 %) |
| Jun 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Sell | S | 64.24 | 28 | 1,799 | 22,557 | 22.6 K to 22.6 K (-0.12 %) |
| Jun 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Sell | S | 63.36 | 9 | 570 | 22,585 | 22.6 K to 22.6 K (-0.04 %) |
| Jun 04 2020 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 64.24 | 29 | 1,863 | 35,448 | 35.5 K to 35.4 K (-0.08 %) |
| Jun 04 2020 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 63.36 | 9 | 570 | 35,477 | 35.5 K to 35.5 K (-0.03 %) |
| Jun 04 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 64.24 | 32 | 2,056 | 39,892 | 39.9 K to 39.9 K (-0.08 %) |
| Jun 04 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 63.36 | 10 | 634 | 39,924 | 39.9 K to 39.9 K (-0.03 %) |
| Jun 04 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 64.24 | 341 | 21,907 | 100,347 | 100.7 K to 100.3 K (-0.34 %) |
| Jun 04 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 63.36 | 103 | 6,526 | 100,688 | 100.8 K to 100.7 K (-0.10 %) |
| Jun 04 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 64.24 | 27 | 1,735 | 27,169 | 27.2 K to 27.2 K (-0.10 %) |
| Jun 04 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 63.36 | 8 | 507 | 27,196 | 27.2 K to 27.2 K (-0.03 %) |
| Jun 04 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 64.24 | 45 | 2,891 | 36,160 | 36.2 K to 36.2 K (-0.12 %) |
| Jun 04 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 63.36 | 14 | 887 | 36,205 | 36.2 K to 36.2 K (-0.04 %) |
| May 05 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Grant | A | 0.00 | 1,361 | 0 | 27,204 | 25.8 K to 27.2 K (+5.27 %) |
| May 05 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Grant | A | 0.00 | 1,511 | 0 | 36,219 | 34.7 K to 36.2 K (+4.35 %) |
| May 05 2020 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Grant | A | 0.00 | 1,437 | 0 | 35,486 | 34 K to 35.5 K (+4.22 %) |
| May 05 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Grant | A | 0.00 | 1,615 | 0 | 39,934 | 38.3 K to 39.9 K (+4.21 %) |
| May 05 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Grant | A | 0.00 | 11,384 | 0 | 100,791 | 89.4 K to 100.8 K (+12.73 %) |
| May 05 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Sell | S | 51.57 | 15 | 774 | 22,594 | 22.6 K to 22.6 K (-0.07 %) |
| May 05 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Sell | S | 50.81 | 45 | 2,287 | 22,609 | 22.7 K to 22.6 K (-0.20 %) |
| May 05 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Sell | S | 49.88 | 172 | 8,579 | 22,654 | 22.8 K to 22.7 K (-0.75 %) |
| May 05 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Grant | A | 0.00 | 1,433 | 0 | 22,826 | 21.4 K to 22.8 K (+6.70 %) |
| Apr 08 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Sell | S | 43.73 | 583 | 25,495 | 21,393 | 22 K to 21.4 K (-2.65 %) |
| Mar 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Option Exercise | A | 73.84 | 20,000 | 1,476,800 | 20,000 | |
| Mar 04 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Grant | A | 0.00 | 10,000 | 0 | 21,976 | 12 K to 22 K (+83.50 %) |
| Mar 04 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | A | 73.84 | 20,000 | 1,476,800 | 20,000 | |
| Mar 04 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Grant | A | 0.00 | 10,000 | 0 | 38,319 | 28.3 K to 38.3 K (+35.31 %) |
| Mar 04 2020 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Option Exercise | A | 73.84 | 20,000 | 1,476,800 | 20,000 | |
| Mar 04 2020 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 23,746 | 13.7 K to 23.7 K (+72.75 %) |
| Mar 04 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Option Exercise | A | 73.84 | 65,000 | 4,799,600 | 65,000 | |
| Mar 04 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Grant | A | 0.00 | 32,500 | 0 | 89,407 | 56.9 K to 89.4 K (+57.11 %) |
| Feb 18 2020 | BLUE | bluebird bio, Inc. | Baird William D III | Chief Financial Off ... | Sell | S | 90.60 | 1,254 | 113,612 | 13,746 | 15 K to 13.7 K (-8.36 %) |
| Jan 14 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 600 | 30,306 | 6,200 | |
| Jan 14 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 94.03 | 600 | 56,416 | 24,708 | 25.3 K to 24.7 K (-2.37 %) |
| Jan 14 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 600 | 30,306 | 25,308 | 24.7 K to 25.3 K (+2.43 %) |
| Jan 09 2020 | BLUE | bluebird bio, Inc. | Smith-Farrell Joanne | Chief Business Offi ... | Sell | S | 89.97 | 408 | 36,708 | 11,976 | 12.4 K to 12 K (-3.29 %) |
| Jan 09 2020 | BLUE | bluebird bio, Inc. | WENTWORTH KORY JAMES | Principal Accountin ... | Sell | S | 89.97 | 223 | 20,064 | 6,308 | 6.5 K to 6.3 K (-3.41 %) |
| Jan 09 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 89.97 | 1,049 | 94,380 | 18,148 | 19.2 K to 18.1 K (-5.46 %) |
| Jan 09 2020 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Operating and | Sell | S | 89.97 | 1,957 | 176,074 | 25,049 | 27 K to 25 K (-7.25 %) |
| Jan 09 2020 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 89.97 | 3,297 | 296,635 | 28,319 | 31.6 K to 28.3 K (-10.43 %) |
| Jan 09 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 89.97 | 4,134 | 371,941 | 24,708 | 28.8 K to 24.7 K (-14.33 %) |
| Jan 09 2020 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 89.97 | 10,163 | 914,377 | 56,712 | 66.9 K to 56.7 K (-15.20 %) |
| Jan 08 2020 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 86.66 | 250 | 21,665 | 28,842 | 29.1 K to 28.8 K (-0.86 %) |
| Jan 07 2020 | BLUE | bluebird bio, Inc. | FINGER ALISON CECILY | Chief Commercial Of ... | Sell | S | 84.96 | 517 | 43,924 | 19,197 | 19.7 K to 19.2 K (-2.62 %) |
| Dec 23 2019 | BLUE | bluebird bio, Inc. | WENTWORTH KORY JAMES | Principal Accountin ... | Sell | S | 92.59 | 397 | 36,758 | 6,449 | 6.8 K to 6.4 K (-5.80 %) |
| Dec 19 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 1,800 | 90,918 | 6,800 | |
| Dec 19 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 94.31 | 1,800 | 169,749 | 29,092 | 30.9 K to 29.1 K (-5.83 %) |
| Dec 19 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 1,800 | 90,918 | 30,892 | 29.1 K to 30.9 K (+6.19 %) |
| Dec 09 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 80.57 | 250 | 20,143 | 29,092 | 29.3 K to 29.1 K (-0.85 %) |
| Nov 07 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 81.95 | 250 | 20,488 | 29,342 | 29.6 K to 29.3 K (-0.84 %) |
| Oct 09 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 89.07 | 250 | 22,267 | 29,592 | 29.8 K to 29.6 K (-0.84 %) |
| Sep 27 2019 | BLUE | bluebird bio, Inc. | Sellers William R. | Director | Option Exercise | A | 105.12 | 8,000 | 840,960 | 8,000 | |
| Sep 27 2019 | BLUE | bluebird bio, Inc. | Sellers William R. | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Sep 11 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 50.51 | 2,060 | 104,051 | 9,625 | |
| Sep 11 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 50.51 | 3,000 | 151,530 | 11,685 | |
| Sep 11 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 100.16 | 2,060 | 206,324 | 31,616 | 33.7 K to 31.6 K (-6.12 %) |
| Sep 11 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 50.51 | 2,060 | 104,051 | 33,676 | 31.6 K to 33.7 K (+6.52 %) |
| Sep 11 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 100.11 | 3,000 | 300,340 | 31,616 | 34.6 K to 31.6 K (-8.67 %) |
| Sep 11 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 50.51 | 3,000 | 151,530 | 34,616 | 31.6 K to 34.6 K (+9.49 %) |
| Sep 09 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 600 | 30,306 | 8,600 | |
| Sep 09 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 101.20 | 850 | 86,018 | 29,842 | 30.7 K to 29.8 K (-2.77 %) |
| Sep 09 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 600 | 30,306 | 30,692 | 30.1 K to 30.7 K (+1.99 %) |
| Aug 21 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Option Exercise | M | 24.47 | 500 | 12,235 | 9,521 | |
| Aug 21 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Sell | S | 124.00 | 500 | 62,000 | 40,921 | 41.4 K to 40.9 K (-1.21 %) |
| Aug 21 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Buy | M | 24.47 | 500 | 12,235 | 41,421 | 40.9 K to 41.4 K (+1.22 %) |
| Aug 12 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 75.60 | 700 | 52,920 | 25,000 | |
| Aug 12 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 124.03 | 950 | 117,824 | 30,092 | 31 K to 30.1 K (-3.06 %) |
| Aug 12 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 75.60 | 700 | 52,920 | 31,042 | 30.3 K to 31 K (+2.31 %) |
| Aug 08 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 50.51 | 5,060 | 255,581 | 14,685 | |
| Aug 08 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 118.44 | 400 | 47,376 | 31,616 | 32 K to 31.6 K (-1.25 %) |
| Aug 08 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 117.77 | 900 | 105,995 | 32,016 | 32.9 K to 32 K (-2.73 %) |
| Aug 08 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 116.11 | 800 | 92,886 | 32,916 | 33.7 K to 32.9 K (-2.37 %) |
| Aug 08 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 115.25 | 2,960 | 341,132 | 33,716 | 36.7 K to 33.7 K (-8.07 %) |
| Aug 08 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 50.51 | 5,060 | 255,581 | 36,676 | 31.6 K to 36.7 K (+16.00 %) |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 75.60 | 700 | 52,920 | 25,700 | |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 600 | 30,306 | 9,800 | |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 131.94 | 100 | 13,194 | 30,592 | 30.7 K to 30.6 K (-0.33 %) |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 130.69 | 300 | 39,207 | 30,692 | 31 K to 30.7 K (-0.97 %) |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 129.70 | 311 | 40,335 | 30,992 | 31.3 K to 31 K (-0.99 %) |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 128.27 | 1,089 | 139,690 | 31,303 | 32.4 K to 31.3 K (-3.36 %) |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 75.60 | 700 | 52,920 | 32,392 | 31.7 K to 32.4 K (+2.21 %) |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 600 | 30,306 | 31,692 | 31.1 K to 31.7 K (+1.93 %) |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 330 | 1,815 | 0 | |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 50.51 | 7,330 | 370,238 | 19,745 | |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 131.77 | 700 | 92,238 | 31,616 | 32.3 K to 31.6 K (-2.17 %) |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 130.05 | 3,300 | 429,153 | 32,316 | 35.6 K to 32.3 K (-9.27 %) |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 129.32 | 832 | 107,592 | 35,616 | 36.4 K to 35.6 K (-2.28 %) |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 128.28 | 2,828 | 362,765 | 36,448 | 39.3 K to 36.4 K (-7.20 %) |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 330 | 1,815 | 39,276 | 38.9 K to 39.3 K (+0.85 %) |
| Jul 09 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 50.51 | 7,330 | 370,238 | 38,946 | 31.6 K to 38.9 K (+23.18 %) |
| Jun 20 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Option Exercise | M | 24.47 | 100 | 2,447 | 10,021 | |
| Jun 20 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Sell | S | 126.12 | 100 | 12,612 | 40,921 | 41 K to 40.9 K (-0.24 %) |
| Jun 20 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Buy | M | 24.47 | 100 | 2,447 | 41,021 | 40.9 K to 41 K (+0.24 %) |
| Jun 12 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Option Exercise | M | 24.47 | 1,400 | 34,258 | 10,121 | |
| Jun 12 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Sell | S | 126.96 | 200 | 25,392 | 40,921 | 41.1 K to 40.9 K (-0.49 %) |
| Jun 12 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Sell | S | 125.19 | 1,200 | 150,227 | 41,121 | 42.3 K to 41.1 K (-2.84 %) |
| Jun 12 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Buy | M | 24.47 | 1,400 | 34,258 | 42,321 | 40.9 K to 42.3 K (+3.42 %) |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Option Exercise | A | 122.01 | 4,000 | 488,040 | 4,000 | |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Grant | A | 0.00 | 1,000 | 0 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Option Exercise | A | 122.01 | 4,000 | 488,040 | 4,000 | |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Grant | A | 0.00 | 1,000 | 0 | 5,176 | 4.2 K to 5.2 K (+23.95 %) |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | MELTON DOUGLAS | Director | Option Exercise | A | 122.01 | 4,000 | 488,040 | 4,000 | |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | MELTON DOUGLAS | Director | Grant | A | 0.00 | 1,000 | 0 | 4,700 | 3.7 K to 4.7 K (+27.03 %) |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | A | 122.01 | 5,600 | 683,256 | 5,600 | |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Grant | A | 0.00 | 1,400 | 0 | 5,600 | 4.2 K to 5.6 K (+33.33 %) |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | DIXON WENDY L | Director | Option Exercise | A | 122.01 | 4,000 | 488,040 | 4,000 | |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | DIXON WENDY L | Director | Grant | A | 0.00 | 1,000 | 0 | 4,000 | 3 K to 4 K (+33.33 %) |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | Agwunobi John O | Director | Option Exercise | A | 122.01 | 4,000 | 488,040 | 4,000 | |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | Agwunobi John O | Director | Grant | A | 0.00 | 1,000 | 0 | 4,700 | 3.7 K to 4.7 K (+27.03 %) |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 50.51 | 5,060 | 255,581 | 27,075 | |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 124.23 | 1,500 | 186,344 | 31,616 | 33.1 K to 31.6 K (-4.53 %) |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 122.43 | 1,344 | 164,550 | 33,116 | 34.5 K to 33.1 K (-3.90 %) |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 121.68 | 2,216 | 269,644 | 34,460 | 36.7 K to 34.5 K (-6.04 %) |
| Jun 10 2019 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 50.51 | 5,060 | 255,581 | 36,676 | 31.6 K to 36.7 K (+16.00 %) |
| Jun 07 2019 | BLUE | bluebird bio, Inc. | WENTWORTH KORY JAMES | Principal Accountin ... | Sell | S | 131.05 | 9 | 1,179 | 6,846 | 6.9 K to 6.8 K (-0.13 %) |
| Jun 07 2019 | BLUE | bluebird bio, Inc. | WENTWORTH KORY JAMES | Principal Accountin ... | Sell | S | 129.51 | 8 | 1,036 | 6,855 | 6.9 K to 6.9 K (-0.12 %) |
| Jun 07 2019 | BLUE | bluebird bio, Inc. | WENTWORTH KORY JAMES | Principal Accountin ... | Sell | S | 127.25 | 17 | 2,163 | 6,863 | 6.9 K to 6.9 K (-0.25 %) |
| Jun 07 2019 | BLUE | bluebird bio, Inc. | WENTWORTH KORY JAMES | Principal Accountin ... | Sell | S | 126.11 | 27 | 3,405 | 6,880 | 6.9 K to 6.9 K (-0.39 %) |
| Jun 05 2019 | BLUE | bluebird bio, Inc. | WENTWORTH KORY JAMES | Principal Accountin ... | Grant | A | 0.00 | 212 | 0 | 6,907 | 6.7 K to 6.9 K (+3.17 %) |
| May 14 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Option Exercise | M | 24.47 | 1,500 | 36,705 | 11,521 | |
| May 14 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Sell | S | 133.08 | 200 | 26,616 | 40,921 | 41.1 K to 40.9 K (-0.49 %) |
| May 14 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Sell | S | 132.38 | 1,100 | 145,613 | 41,121 | 42.2 K to 41.1 K (-2.61 %) |
| May 14 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Sell | S | 131.11 | 200 | 26,221 | 42,221 | 42.4 K to 42.2 K (-0.47 %) |
| May 14 2019 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Strategy Offi ... | Buy | M | 24.47 | 1,500 | 36,705 | 42,421 | 40.9 K to 42.4 K (+3.67 %) |
| May 08 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 75.60 | 700 | 52,920 | 27,100 | |
| May 08 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 600 | 30,306 | 11,000 | |
| May 08 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 75.60 | 700 | 52,920 | 27,100 | |
| May 08 2019 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 138.93 | 600 | 83,358 | 31,592 | 32.2 K to 31.6 K (-1.86 %) |